INBUILD Trademark

Trademark Overview

On Thursday, October 13, 2016, a trademark application was filed for INBUILD with the United States Patent and Trademark Office. The USPTO has given the INBUILD trademark a serial number of 79196656. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, February 4, 2025. This trademark is owned by Boehringer Ingelheim International GmbH. The INBUILD trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the fields of respiratory diseases and oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
inbuild

General Information

Serial Number79196656
Word MarkINBUILD
Filing DateThursday, October 13, 2016
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, February 4, 2025
Registration Number5577714
Registration DateTuesday, October 9, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 24, 2018

Trademark Statements

Pseudo MarkIN BUILD
Goods and ServicesMedical and scientific research in the fields of respiratory diseases and oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, November 29, 2016
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressIngelheim 55218
DE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Friday, December 9, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, November 24, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, November 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 3, 2016APPLICATION FILING RECEIPT MAILED
Wednesday, December 7, 2016ASSIGNED TO EXAMINER
Thursday, December 8, 2016NON-FINAL ACTION WRITTEN
Friday, December 9, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, December 9, 2016REFUSAL PROCESSED BY MPU
Monday, November 6, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 30, 2016REFUSAL PROCESSED BY IB
Tuesday, April 4, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 2, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 2, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 3, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 5, 2017NON-FINAL ACTION WRITTEN
Friday, May 5, 2017NON-FINAL ACTION E-MAILED
Friday, May 5, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 6, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 8, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 25, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, May 22, 2018EXPARTE APPEAL RECEIVED AT TTAB
Tuesday, May 22, 2018JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, May 22, 2018EX PARTE APPEAL-INSTITUTED
Tuesday, May 29, 2018ASSIGNED TO LIE
Wednesday, November 22, 2017FINAL REFUSAL WRITTEN
Wednesday, November 22, 2017FINAL REFUSAL E-MAILED
Wednesday, November 22, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 25, 2018NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, May 11, 2018NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, May 22, 2018TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, July 4, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, July 24, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, May 31, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 31, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 14, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 4, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 4, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 24, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 9, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 6, 2024TEAS SECTION 71 RECEIVED
Thursday, August 23, 2018ASSIGNED TO EXAMINER
Thursday, September 13, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, October 6, 2018NOTIFICATION PROCESSED BY IB
Tuesday, October 9, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, January 23, 2019FINAL DISPOSITION PROCESSED
Wednesday, January 23, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 8, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, October 9, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, February 3, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, February 4, 2025REGISTERED-SEC.71 ACCEPTED
Tuesday, February 4, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

Related Keywords

inbuild medical research scientific field pharmaceuticals trials information clinical oncology fields